We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+11.24%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$23.8B
AUM Growth
+$2.31B
Cap. Flow
+$456M
Cap. Flow %
1.91%
Top 10 Hldgs %
40.08%
Holding
618
New
69
Increased
199
Reduced
226
Closed
78

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$468M
2
UNH icon
UnitedHealth
UNH
+$196M
3
PYPL icon
PayPal
PYPL
+$184M
4
UNP icon
Union Pacific
UNP
+$184M
5
BA icon
Boeing
BA
+$179M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$250M
2
ABBV icon
AbbVie
ABBV
+$180M
3
NOW icon
ServiceNow
NOW
+$123M
4
EA icon
Electronic Arts
EA
+$107M
5
CMCSA icon
Comcast
CMCSA
+$102M

Sector Composition

Rank Sector Weight
1 Technology 26.75%
2 Healthcare 17.43%
3 Consumer Discretionary 16.31%
4 Communication Services 10.62%
5 Financials 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYNB
376
Kyntra Bio
KYNB
$28.5M
$313K ﹤0.01%
+200
New +$261K
MKC icon
377
McCormick & Company Non-Voting
MKC
$13.4B
$310K ﹤0.01%
5,346
-790
-13% -$41.5K
BOLD
378
DELISTED
Audentes Therapeutics, Inc
BOLD
$306K ﹤0.01%
+8,000
New +$296K
ADAP
379
DELISTED
Adaptimmune Therapeutics
ADAP
$297K ﹤0.01%
+25,000
New +$312K
EHC icon
380
Encompass Health
EHC
$11.2B
$271K ﹤0.01%
+5,028
New +$251K
AIMT
381
DELISTED
Aimmune Therapeutics
AIMT
$269K ﹤0.01%
+10,000
New +$306K
ARGX icon
382
argenx
ARGX
$57.4B
$249K ﹤0.01%
3,000
+1,000
+50% +$89.4K
SRRA
383
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$246K ﹤0.01%
+2,075
New +$208K
NVCR icon
384
NovoCure
NVCR
$2.04B
$219K ﹤0.01%
+7,000
New +$195K
LGND icon
385
Ligand Pharmaceuticals
LGND
$6.02B
$207K ﹤0.01%
+1,603
New +$179K
PGC icon
386
Peapack-Gladstone Financial
PGC
$822M
$160K ﹤0.01%
4,614
+362
+9% +$12.3K
LOMA
387
Loma Negra
LOMA
$1.33B
$142K ﹤0.01%
13,802
-16,442
-54% -$271K
RARX
388
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$139K ﹤0.01%
14,000
– –
MRNS
389
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$127K ﹤0.01%
4,500
– –
VMW
390
DELISTED
VMware, Inc
VMW
$113K ﹤0.01%
766
-356,057
-100% -$49.1M
IWF icon
391
iShares Russell 1000 Growth ETF
IWF
$122B
$107K ﹤0.01%
2,968
-4,712
-61% -$166K
IOVA icon
392
Iovance Biotherapeutics
IOVA
$2.23B
$102K ﹤0.01%
+8,000
New +$117K
HIND
393
Vyome Holdings
HIND
$14.5M
– –
0
– –
DERM
394
DELISTED
Dermira, Inc.
DERM
$101K ﹤0.01%
11,000
– –
KIN
395
DELISTED
Kindred Biosciences, Inc.
KIN
$96K ﹤0.01%
+9,000
New +$87.8K
VRSK icon
396
Verisk Analytics
VRSK
$26.4B
$94K ﹤0.01%
872
+123
+16% +$13.1K
LYB icon
397
LyondellBasell Industries
LYB
$19.5B
$93K ﹤0.01%
843
+304
+56% +$33.4K
CAT icon
398
Caterpillar
CAT
$409B
$90K ﹤0.01%
665
-373,562
-100% -$55.8M
TROW icon
399
T. Rowe Price
TROW
$25B
$89K ﹤0.01%
764
+349
+84% +$40.6K
TRU icon
400
TransUnion
TRU
$14.8B
$88K ﹤0.01%
1,232
-57
-4% -$3.8K
14 15
16
17 18

Similar funds

Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
AM
AGF Management Toronto, Ontario, Canada $22.3B AUM 46.42% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

Fred Alger Management's Q2 2018 Portfolio in Review

As of Q2 2018, Fred Alger Management held 618 positions worth $23.8B, up 11% from $21.5B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Fred Alger Management's Q2 2018 filing shows 69 new, 199 increased, 226 reduced and 78 closed positions. Its largest new stake was Broadcom: 19,086,990 shares worth $463M. The largest sale was Bank of America, an estimated $250M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Fred Alger Management's largest Q2 2018 buy was Broadcom: 19,086,990 shares worth $463M.
  • Fred Alger Management added most to UnitedHealth in Q2 2018, an estimated $196M increase.
  • Fred Alger Management's biggest Q2 2018 reduction was Bank of America, cutting an estimated $250M.
  • Fred Alger Management fully exited International Paper in Q2 2018, selling an estimated $58.7M.
  • Fred Alger Management's ten largest holdings make up 40% of its $23.8B portfolio in Q2 2018.
  • Fred Alger Management opened 69 new positions and closed 78 in Q2 2018.
  • Fred Alger Management's portfolio value rose 11% quarter-over-quarter to $23.8B.

Based on Fred Alger Management's 13F filing for Q2 2018, filed 19 Jul 2018.